Senior insider sale
Chief Technical Ops Officer at PTC THERAPEUTICS, INC. — senior position signals high conviction
$8.96M
104.94K shares
What this filing means
ALMSTEAD NEIL GREGORY plans to sell 104.94K shares of PTC THERAPEUTICS, INC. valued at approximately $8.96M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001959173-26-005150
Officer· Chief Technical Ops Officer
Since Jan 2019
104.94K
Shares to sell
$8.96M
Approx. market value
24.61K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/7/2026
24.61KTotal acquired24.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/7/2026 | Stock Option Exercise Cash | 24.61K | — |
| Total | 24.61K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
22.16K
Market value
$1.91M
7/6/2026
—Completed
Units to sell
8.13K
Market value
$693.1K
6/26/2026
—Completed
Units to sell
20.96K
Market value
$1.80M
6/25/2026
—Completed
Units to sell
5.32K
Market value
$452.6K
6/24/2026
—Completed
Units to sell
23.75K
Market value
$1.92M
6/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
24.61K
Market value
$2.19M
7/7/2026
Total
Units
104.94K
Value
$8.96M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/6/2026 | 22.16K | $1.91M | — | Completed |
6/26/2026 | 8.13K | $693.1K | — | Completed |
6/25/2026 | 20.96K | $1.80M | — | Completed |
6/24/2026 | 5.32K | $452.6K | — | Completed |
6/22/2026 | 23.75K | $1.92M | — | Completed |
| Planned — Approximate Date | ||||
7/7/2026 | 24.61K | $2.19M | NASDAQ | Planned |
| Total | 104.94K | $8.96M | ||